Trial Profile
Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms CLEAR-PCI
- 05 Nov 2013 New trial record